Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China flag China · Delayed Price · Currency is CNY
281.00
-1.83 (-0.65%)
At close: Feb 6, 2026

SHA:688506 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
116,01876,88456,100---
Market Cap Growth
61.09%37.05%----
Enterprise Value
113,63173,45856,019---
Last Close Price
281.00191.73139.90---
PE Ratio
-20.74----
Forward PE
-71.91----
PS Ratio
52.1213.2099.85---
PB Ratio
16.1819.79369.39---
P/TBV Ratio
16.2419.92452.87---
P/FCF Ratio
-19.34----
P/OCF Ratio
-18.94----
EV/Sales Ratio
51.0512.6299.70---
EV/EBITDA Ratio
-19.57----
EV/EBIT Ratio
-19.93----
EV/FCF Ratio
-44.6018.48----
Debt / Equity Ratio
0.530.534.530.590.870.33
Debt / EBITDA Ratio
-0.55---5.68
Debt / FCF Ratio
-0.52---2.38
Asset Turnover
0.231.360.330.480.800.95
Inventory Turnover
1.501.872.002.592.752.82
Quick Ratio
3.772.990.521.730.620.89
Current Ratio
5.313.190.741.940.901.07
Return on Equity (ROE)
-14.94%183.64%-143.77%-44.62%-25.51%8.62%
Return on Assets (ROA)
-5.41%53.82%-28.74%-14.01%-10.00%-1.34%
Return on Invested Capital (ROIC)
-32.12%1077.87%-172.17%-70.10%-38.81%-5.18%
Return on Capital Employed (ROCE)
-8.20%71.50%-211.60%-26.30%-33.20%-4.50%
Earnings Yield
-0.73%4.82%-1.39%---
FCF Yield
-2.20%5.17%-1.24%---
Payout Ratio
-1.03%---26.28%
Buyback Yield / Dilution
-0.63%-0.14%-10.56%-1.38%-3.64%10.86%
Total Shareholder Return
-0.63%-0.14%-10.56%-1.38%-3.64%10.86%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.